Global Sofosbuvir (CAS 1190307-88-0) Market Outlook 2021

Publisher Name :
Date: 19-Nov-2020
No. of pages: 97
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Sofosbuvir (CAS 1190307-88-0) market is segmented into

- Purity = 98%

- Purity < 98%

Segment by Application

- Adults Patients

- Elderly Patients

Global Sofosbuvir (CAS 1190307-88-0) Market: Regional Analysis

The Sofosbuvir (CAS 1190307-88-0) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Sofosbuvir (CAS 1190307-88-0) market report are:

- North America

- U.S.

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

- Latin America

- Mexico

- Brazil

- Argentina

- Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Sofosbuvir (CAS 1190307-88-0) Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Sofosbuvir (CAS 1190307-88-0) market include:

- Teva Pharmaceutical Industries Ltd

- DONG BANG FUTURE TECH & LIFE CO., LTD

- Beaukev Pharma International Pvt.Ltd

- DEAFARMA

- Tecoland

- Anhui HaiKang Pharmaceutical Co. Ltd

- Shanghai Haoyuan Chemexpress Co., Ltd

- Beijing Kawin Technology Share-holding Co

- Hangzhou Longshine Bio-Tech Co

Global Sofosbuvir (CAS 1190307-88-0) Market Outlook 2021

Table of Contents
1 Sofosbuvir (CAS 1190307-88-0) Market Overview
1.1 Product Overview and Scope of Sofosbuvir (CAS 1190307-88-0)
1.2 Sofosbuvir (CAS 1190307-88-0) Segment by Type
1.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Purity = 98%
1.2.3 Purity < 98%
1.3 Sofosbuvir (CAS 1190307-88-0) Segment by Application
1.3.1 Sofosbuvir (CAS 1190307-88-0) Sales Comparison by Application: (2020-2026)
1.3.2 Adults Patients
1.3.3 Elderly Patients
1.4 Global Sofosbuvir (CAS 1190307-88-0) Market Size Estimates and Forecasts
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue 2015-2026
1.4.2 Global Sofosbuvir (CAS 1190307-88-0) Sales 2015-2026
1.4.3 Sofosbuvir (CAS 1190307-88-0) Market Size by Region: 2020 Versus 2026
2 Global Sofosbuvir (CAS 1190307-88-0) Market Competition by Manufacturers
2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2015-2020)
2.3 Global Sofosbuvir (CAS 1190307-88-0) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Sofosbuvir (CAS 1190307-88-0) Manufacturing Sites, Area Served, Product Type
2.5 Sofosbuvir (CAS 1190307-88-0) Market Competitive Situation and Trends
2.5.1 Sofosbuvir (CAS 1190307-88-0) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Sofosbuvir (CAS 1190307-88-0) Players (Opinion Leaders)
3 Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario by Region
3.1 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Country
3.3.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.3.2 North America Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Country
3.4.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.4.2 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Region
3.5.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region
3.5.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Country
3.6.1 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.6.2 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Country
3.7.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.7.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Analysis by Type
4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
4.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2015-2020)
4.3 Global Sofosbuvir (CAS 1190307-88-0) Price Market Share by Type (2015-2020)
4.4 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Analysis by Application
5.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2015-2020)
5.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Sofosbuvir (CAS 1190307-88-0) Business
6.1 Teva Pharmaceutical Industries Ltd
6.1.1 Corporation Information
6.1.2 Teva Pharmaceutical Industries Ltd Description, Business Overview
6.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Teva Pharmaceutical Industries Ltd Products Offered
6.1.5 Teva Pharmaceutical Industries Ltd Recent Development
6.2 DONG BANG FUTURE TECH & LIFE CO., LTD
6.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
6.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Description, Business Overview
6.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Products Offered
6.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
6.3 Beaukev Pharma International Pvt.Ltd
6.3.1 Beaukev Pharma International Pvt.Ltd Corporation Information
6.3.2 Beaukev Pharma International Pvt.Ltd Description, Business Overview
6.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Beaukev Pharma International Pvt.Ltd Products Offered
6.3.5 Beaukev Pharma International Pvt.Ltd Recent Development
6.4 DEAFARMA
6.4.1 DEAFARMA Corporation Information
6.4.2 DEAFARMA Description, Business Overview
6.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 DEAFARMA Products Offered
6.4.5 DEAFARMA Recent Development
6.5 Tecoland
6.5.1 Tecoland Corporation Information
6.5.2 Tecoland Description, Business Overview
6.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Tecoland Products Offered
6.5.5 Tecoland Recent Development
6.6 Anhui HaiKang Pharmaceutical Co. Ltd
6.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
6.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Description, Business Overview
6.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Products Offered
6.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
6.7 Shanghai Haoyuan Chemexpress Co., Ltd
6.6.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
6.6.2 Shanghai Haoyuan Chemexpress Co., Ltd Description, Business Overview
6.6.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Shanghai Haoyuan Chemexpress Co., Ltd Products Offered
6.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
6.8 Beijing Kawin Technology Share-holding Co
6.8.1 Beijing Kawin Technology Share-holding Co Corporation Information
6.8.2 Beijing Kawin Technology Share-holding Co Description, Business Overview
6.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Beijing Kawin Technology Share-holding Co Products Offered
6.8.5 Beijing Kawin Technology Share-holding Co Recent Development
6.9 Hangzhou Longshine Bio-Tech Co
6.9.1 Hangzhou Longshine Bio-Tech Co Corporation Information
6.9.2 Hangzhou Longshine Bio-Tech Co Description, Business Overview
6.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hangzhou Longshine Bio-Tech Co Products Offered
6.9.5 Hangzhou Longshine Bio-Tech Co Recent Development
7 Sofosbuvir (CAS 1190307-88-0) Manufacturing Cost Analysis
7.1 Sofosbuvir (CAS 1190307-88-0) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
7.4 Sofosbuvir (CAS 1190307-88-0) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sofosbuvir (CAS 1190307-88-0) Distributors List
8.3 Sofosbuvir (CAS 1190307-88-0) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Sofosbuvir (CAS 1190307-88-0) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sofosbuvir (CAS 1190307-88-0) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Sofosbuvir (CAS 1190307-88-0) by Type (2021-2026)
10.2 Sofosbuvir (CAS 1190307-88-0) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sofosbuvir (CAS 1190307-88-0) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Sofosbuvir (CAS 1190307-88-0) by Application (2021-2026)
10.3 Sofosbuvir (CAS 1190307-88-0) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sofosbuvir (CAS 1190307-88-0) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Sofosbuvir (CAS 1190307-88-0) by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Sofosbuvir (CAS 1190307-88-0) Manufacturers Covered in This Study
Table 5. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Manufacturers (2015-2020)
Table 7. Global Sofosbuvir (CAS 1190307-88-0) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Sofosbuvir (CAS 1190307-88-0) Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Sofosbuvir (CAS 1190307-88-0) Sales Sites and Area Served
Table 11. Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Types
Table 12. Global Sofosbuvir (CAS 1190307-88-0) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sofosbuvir (CAS 1190307-88-0) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sofosbuvir (CAS 1190307-88-0) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Sofosbuvir (CAS 1190307-88-0) Players
Table 16. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) by Region (2015-2020)
Table 17. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Table 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Table 20. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 21. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 22. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 24. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 25. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 26. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 33. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 34. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 40. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) by Type (2015-2020)
Table 41. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2015-2020)
Table 42. Global Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2015-2020)
Table 44. Global Sofosbuvir (CAS 1190307-88-0) Price (USD/MT) by Type (2015-2020)
Table 45. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) by Application (2015-2020)
Table 46. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 47. Global Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate by Application (2015-2020)
Table 48. Teva Pharmaceutical Industries Ltd Corporation Information
Table 49. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 50. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Teva Pharmaceutical Industries Ltd Main Product
Table 52. Teva Pharmaceutical Industries Ltd Recent Development
Table 53. DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
Table 54. DONG BANG FUTURE TECH & LIFE CO., LTD Description and Business Overview
Table 55. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. DONG BANG FUTURE TECH & LIFE CO., LTD Main Product
Table 57. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
Table 58. Beaukev Pharma International Pvt.Ltd Corporation Information
Table 59. Beaukev Pharma International Pvt.Ltd Description and Business Overview
Table 60. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Beaukev Pharma International Pvt.Ltd Main Product
Table 62. Beaukev Pharma International Pvt.Ltd Recent Development
Table 63. DEAFARMA Corporation Information
Table 64. DEAFARMA Description and Business Overview
Table 65. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. DEAFARMA Main Product
Table 67. DEAFARMA Recent Development
Table 68. Tecoland Corporation Information
Table 69. Tecoland Description and Business Overview
Table 70. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Tecoland Main Product
Table 72. Tecoland Recent Development
Table 73. Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
Table 74. Anhui HaiKang Pharmaceutical Co. Ltd Description and Business Overview
Table 75. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Anhui HaiKang Pharmaceutical Co. Ltd Main Product
Table 77. Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
Table 78. Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
Table 79. Shanghai Haoyuan Chemexpress Co., Ltd Description and Business Overview
Table 80. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Shanghai Haoyuan Chemexpress Co., Ltd Main Product
Table 82. Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
Table 83. Beijing Kawin Technology Share-holding Co Corporation Information
Table 84. Beijing Kawin Technology Share-holding Co Description and Business Overview
Table 85. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Beijing Kawin Technology Share-holding Co Main Product
Table 87. Beijing Kawin Technology Share-holding Co Recent Development
Table 88. Hangzhou Longshine Bio-Tech Co Corporation Information
Table 89. Hangzhou Longshine Bio-Tech Co Description and Business Overview
Table 90. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Hangzhou Longshine Bio-Tech Co Main Product
Table 92. Hangzhou Longshine Bio-Tech Co Recent Development
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Sofosbuvir (CAS 1190307-88-0) Distributors List
Table 96. Sofosbuvir (CAS 1190307-88-0) Customers List
Table 97. Sofosbuvir (CAS 1190307-88-0) Market Trends
Table 98. Sofosbuvir (CAS 1190307-88-0) Opportunities and Drivers
Table 99. Sofosbuvir (CAS 1190307-88-0) Market Challenges
Table 100. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) Forecast by Type (2021-2026)
Table 101. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) Forecast by Application (2021-2026)
Table 105. Global Sofosbuvir (CAS 1190307-88-0) Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Sofosbuvir (CAS 1190307-88-0) Sales (MT) Forecast by Region (2021-2026)
Table 107. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Sofosbuvir (CAS 1190307-88-0)
Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type: 2020 VS 2026
Figure 3. Purity = 98% Product Picture
Figure 4. Purity < 98% Product Picture
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Adults Patients
Figure 7. Elderly Patients
Figure 8. Global Sofosbuvir (CAS 1190307-88-0) Market Size 2015-2026 (US$ Million)
Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Sales Capacity (MT) (2015-2026)
Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Sofosbuvir (CAS 1190307-88-0) Sales Share by Manufacturers in 2020
Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2019
Figure 14. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Figure 16. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2019
Figure 17. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Figure 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in 2019
Figure 19. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 20. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 21. U.S. Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 22. U.S. Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 24. Canada Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 26. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 27. Germany Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 28. Germany Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 30. France Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 32. U.K. Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 34. Italy Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 36. Russia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2019
Figure 38. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in 2019
Figure 39. China Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 40. China Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 42. Japan Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 44. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 46. India Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 48. Australia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 50. Taiwan Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 52. Indonesia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 54. Thailand Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 56. Malaysia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 58. Philippines Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 60. Vietnam Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 62. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 63. Mexico Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 64. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 66. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 68. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 71. Turkey Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 72. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 74. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 76. U.A.E Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Sofosbuvir (CAS 1190307-88-0) by Type (2015-2020)
Figure 78. Sales Market Share of Sofosbuvir (CAS 1190307-88-0) by Type in 2020
Figure 79. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Price Range (2015-2020)
Figure 80. Revenue Market Share of Sofosbuvir (CAS 1190307-88-0) by Type in 2019
Figure 81. Global Sofosbuvir (CAS 1190307-88-0) Sales Growth by Type (2015-2020) (MT)
Figure 82. Sales Market Share of Sofosbuvir (CAS 1190307-88-0) by Application (2015-2020)
Figure 83. Sales Market Share of Sofosbuvir (CAS 1190307-88-0) by Application in 2020
Figure 84. Revenue Share of Sofosbuvir (CAS 1190307-88-0) by Application (2015-2020)
Figure 85. Revenue Share of Sofosbuvir (CAS 1190307-88-0) by Application in 2020
Figure 86. Key Raw Materials Price Trend
Figure 87. Manufacturing Cost Structure of Sofosbuvir (CAS 1190307-88-0)
Figure 88. Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
Figure 89. Sofosbuvir (CAS 1190307-88-0) Industrial Chain Analysis
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Porter's Five Forces Analysis
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
  • (Post-pandemic Era) - Global Xenon Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Wine Corks Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 119
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Wind Turbine Blade Coatings Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 118
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Waterborne Epoxy Resin Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 115
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vinyl Composition Tile (VCT) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 118
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vapor Corrosion Inhibitor Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vanadium Pentoxide Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 116
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global UV Inks Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 114
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Unsaturated Polyester Resin (UPR) for Composites Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 116
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs